Search results for "Keeping tabs"
Spotlight on psychological impacts
Managing diabetes can negatively impact quality of life for people with the disease, so doctors should consider a patient's treatment burden and the “whole person” when setting goals, 2 studies suggest.
https://diabetes.acponline.org/archives/2014/07/11/9.htm
11 Jul 2014
Spotlight on diabetes medications and cancer risks
The risks of cancer in patients taking medication for diabetes were analyzed by 2 recent studies.
https://diabetes.acponline.org/archives/2013/12/13/8.htm
13 Dec 2013
Spotlight on type 1 diabetes
A couple of significant studies in type 1 diabetes came out last month.
https://diabetes.acponline.org/archives/2014/12/12/8.htm
12 Dec 2014
Spotlight on cardiovascular disease in women with diabetes
Two recent studies looked at cardiovascular disease (CVD) risk in women with type 2 diabetes, finding that fenofibrate may be associated with lowered risk and sulfonylureas with increased risk.
https://diabetes.acponline.org/archives/2014/09/12/8.htm
12 Sep 2014
Spotlight on bariatric surgery
Treatment of type 2 diabetes with bariatric surgery was discussed by several recent publications, including updated guidelines from a group of medical specialty organizations.
https://diabetes.acponline.org/archives/2013/05/10/14.htm
10 May 2013
Spotlight on statins in diabetes
Recent studies looked at how statins negatively affect glycemic control but improve cardiovascular mortality, as well as the reasons patients with diabetes don't receive prescriptions for statins despite recommendations.
https://diabetes.acponline.org/archives/2023/04/14/5.htm
14 Apr 2023
Spotlight on self-management
One study found that personalized text messaging improved patients' self-management while another looked at the potential value of providing social comparisons to other patients' diabetes control.
https://diabetes.acponline.org/archives/2018/06/08/5.htm
8 Jun 2018
Spotlight on diabetes drug class comparisons
A large trial compared insulin, a sulfonylurea, a glucagon-like peptide-1 (GLP-1) receptor agonist, and a dipeptidyl peptidase-4 inhibitor as second-line therapy, while a modeling study considered GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors as first-line agents.
https://diabetes.acponline.org/archives/2022/10/14/5.htm
14 Oct 2022
Spotlight on resistance training
Several recent studies found modest benefits to patients with type 1 or type 2 diabetes participating in strengthening exercises.
https://diabetes.acponline.org/archives/2022/12/09/5.htm
9 Dec 2022
Spotlight on metformin
Metformin—including its use, effects, and mechanisms—was the focus of some research published in the past month.
https://diabetes.acponline.org/archives/2014/11/14/9.htm
14 Nov 2014